Medicus Pharma (MDCX) Debt Ratio (2025 - 2026)
Medicus Pharma's (MDCX) quarterly Debt Ratio came in at 0.52 in Q4 2025, down 23.3% on a QoQ basis from 0.68 in Q3 2025.
Medicus Pharma (MDCX) Debt Ratio (2025 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 1 years of Debt Ratio data on file, last reported at 0.52 in Q4 2025.
- Quarterly Debt Ratio changed N/A year-over-year to 0.52 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.52 (changed N/A YoY) and the FY2025 annual result came in at 0.52, changed N/A from the prior year.
- Debt Ratio declined to 0.52 in Q4 2025, from 0.68 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.68 in Q3 2025 to a low of 0.39 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -0.31 |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | 0.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.79 |
| Dec 31, 2025 | 0.52 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.39 |